全球首例！我国实现再生胰岛移植

Core Viewpoint - The article discusses a groundbreaking achievement in the treatment of Type 1 diabetes through the use of regenerated islets (E-islet) derived from both autologous and allogeneic stem cells, marking a significant advancement in diabetes management and potential cure [3][4][6]. Group 1: Research and Development - A new technology system based on endodermal stem cells has been established over two decades, leading to the successful creation of E-islets for treating severely impaired pancreatic function in diabetes patients [4]. - Clinical studies involving three patients demonstrated that both autologous and allogeneic E-islet transplants can restore pancreatic function and enable blood sugar control without external insulin dependency [6]. Group 2: Clinical Implications - The research team has proven that E-islet transplantation can significantly improve blood sugar levels and reduce the occurrence and progression of complications associated with Type 1 diabetes [6]. - Current treatment still requires long-term immunosuppressive therapy to prevent autoimmune relapse, but future plans include gene editing to modify the E-islets to avoid immune system recognition, aiming for a complete cure of diabetes [6].